Literature DB >> 33178738

Precision Medicine.

Florian Lordick1, Michael Ghadimi2, Ines Gockel3, Ulrich Graeven4, C Benedikt Westphalen5.   

Abstract

Year:  2020        PMID： 33178738      PMCID： PMC7590746          DOI： 10.1159/000511534

Source DB:  PubMed          Journal:  Visc Med        ISSN： 2297-4725


× No keyword cloud information.
  6 in total

1.  Chemotherapy for resectable microsatellite instability-high gastric cancer?

Authors:  Florian Lordick
Journal:  Lancet Oncol       Date:  2020-02       Impact factor: 41.316

2.  Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.

Authors:  Filippo Pietrantonio; Rosalba Miceli; Alessandra Raimondi; Young Woo Kim; Won Ki Kang; Ruth E Langley; Yoon Young Choi; Kyoung-Mee Kim; Matthew Guy Nankivell; Federica Morano; Andrew Wotherspoon; Nicola Valeri; Myeong-Cherl Kook; Ji Yeong An; Heike I Grabsch; Giovanni Fucà; Sung Hoon Noh; Tae Sung Sohn; Sung Kim; Maria Di Bartolomeo; David Cunningham; Jeeyun Lee; Jae-Ho Cheong; Elizabeth Catherine Smyth
Journal:  J Clin Oncol       Date:  2019-09-12       Impact factor: 44.544

3.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Authors:  E Van Cutsem; A Cervantes; R Adam; A Sobrero; J H Van Krieken; D Aderka; E Aranda Aguilar; A Bardelli; A Benson; G Bodoky; F Ciardiello; A D'Hoore; E Diaz-Rubio; J-Y Douillard; M Ducreux; A Falcone; A Grothey; T Gruenberger; K Haustermans; V Heinemann; P Hoff; C-H Köhne; R Labianca; P Laurent-Puig; B Ma; T Maughan; K Muro; N Normanno; P Österlund; W J G Oyen; D Papamichael; G Pentheroudakis; P Pfeiffer; T J Price; C Punt; J Ricke; A Roth; R Salazar; W Scheithauer; H J Schmoll; J Tabernero; J Taïeb; S Tejpar; H Wasan; T Yoshino; A Zaanan; D Arnold
Journal:  Ann Oncol       Date:  2016-07-05       Impact factor: 32.976

4.  Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Authors:  Talia Golan; Pascal Hammel; Michele Reni; Eric Van Cutsem; Teresa Macarulla; Michael J Hall; Joon-Oh Park; Daniel Hochhauser; Dirk Arnold; Do-Youn Oh; Anke Reinacher-Schick; Giampaolo Tortora; Hana Algül; Eileen M O'Reilly; David McGuinness; Karen Y Cui; Katia Schlienger; Gershon Y Locker; Hedy L Kindler
Journal:  N Engl J Med       Date:  2019-06-02       Impact factor: 91.245

5.  EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.

Authors:  Anna Dorothea Wagner; Heike I Grabsch; Murielle Mauer; Sandrine Marreaud; Carmela Caballero; Peter Thuss-Patience; Lothar Mueller; Annelie Elme; Markus Hermann Moehler; Uwe Martens; Yoon-Koo Kang; Sun Young Rha; Annemieke Cats; Masanori Tokunaga; Florian Lordick
Journal:  BMC Cancer       Date:  2019-05-24       Impact factor: 4.430

Review 6.  Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'.

Authors:  Benedikt C Westphalen; Carsten Bokemeyer; Reinhard Büttner; Stefan Fröhling; Verena I Gaidzik; Hanno Glimm; Ulrich T Hacker; Volker Heinemann; Anna L Illert; Ulrich Keilholz; Thomas Kindler; Martin Kirschner; Bastian Schilling; Jens T Siveke; Thomas Schroeder; Verena Tischler; Sebastian Wagner; Wilko Weichert; Daniel Zips; Sonja Loges
Journal:  Eur J Cancer       Date:  2020-06-07       Impact factor: 9.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.